Tilray | TRLY - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Acasti Pharma USD 64.89M 2.07M 2025-12
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alaunos Therapeutics USD 1.29M 865K 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Canopy Growth CAD 697.59M 60.58M 2026-03
Cronos Group USD 1.07B 20.24M 2026-03
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Moderna USD 7.41B 1.24B 2026-03
Organigram Holdings CAD 371.81M 2.36M 2026-03
Organon & Co USD 903M 151M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 14.66B 53.6M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03
Zealand Pharma A/S 14.83B 331.99M 2025-12